表紙
市場調査レポート

米国のヘルスケアBPO市場:保険者・プロバイダー・医薬品‐動向と世界市場予測

U.S. Healthcare BPO Market - Payer (Claims Processing, HR Services, & Finance & Accounts) Provider (Medical Billing & Coding) & Pharmaceutical (Clinical Trials, Contract Manufacturing, & Non-Clinical Services) - Trends & Global Forecasts to 2018

発行 MarketsandMarkets 商品コード 227818
出版日 ページ情報 英文 259 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
米国のヘルスケアBPO市場:保険者・プロバイダー・医薬品‐動向と世界市場予測 U.S. Healthcare BPO Market - Payer (Claims Processing, HR Services, & Finance & Accounts) Provider (Medical Billing & Coding) & Pharmaceutical (Clinical Trials, Contract Manufacturing, & Non-Clinical Services) - Trends & Global Forecasts to 2018
出版日: 2013年08月05日 ページ情報: 英文 259 Pages
概要

当レポートでは、米国のヘルスケアBPO市場について調査分析を行い、セグメント(保険者・プロバイダー・医薬品)別およびサービスに基づいた2次セグメント別に分類して分析しており、市場額の分析と予測、競合状況、および主要企業のプロファイルなどについてまとめ、概略下記の構成で取り上げております。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • イントロダクション
  • 市場力学

第4章 米国のヘルスケア保険者アウトソーシング市場:サービス別

  • イントロダクション
  • 請求処理
  • 会員サービス/顧客ケア
  • HRサービス
  • 経理/会計

第5章 米国のヘルスケアプロバイダーアウトソーシング市場:サービス別

  • イントロダクション
  • 医療費請求
  • 医療事務
  • 医療資料作成
  • 経理/会計

第6章 米国の医薬品アウトソーシング市場:種類別

  • イントロダクション
  • 米国のCRO市場
  • 米国のCMO市場
  • 米国の非臨床サービスアウトソーシング市場

第7章 地域別分析

  • 米国

第8章 競合状況

  • イントロダクション
  • M&A
  • 合意、提携、協力およびジョイントベンチャー
  • 新製品発売
  • 拡大

第9章 企業プロファイル(概要、財務、サービス、戦略および発展動向)

  • Accenture Plc
  • Accretive Health, Inc.
  • Anthelio Healthcare Solutions, Inc.
  • Boehringer Ingelheim Gmbh
  • Catalent Pharma Solutions, Inc.
  • Cognizant Technology Solutions Corporation
  • Covance, Inc.
  • GEBBS Healthcare Solutions, Inc.
  • Genpact Limited
  • IBM Corporation
  • ICON Plc
  • Infosys Bpo Limited
  • LONZA Group Ltd.
  • Parexel International Corporation
  • Quintiles Transnational Holdings, Inc.
  • WNS (Holdings) Limited

図表リスト

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: HIT 2088

Abstract

Report Description

The U.S. healthcare outsourcing market has great potential for growth owing to the measures taken by the government to curb the ever-increasing healthcare costs. The other factors that have led to the growth of the market are: developments and innovation in information technology and regulatory changes. Approximately 75% of U.S. healthcare companies outsource their work to external locations. This is due to the shortage of qualified staff in key positions, such as nurses and coders, and due to the new set of rules and regulations that they need to comply with. Some services that are commonly outsourced are insurance claims processing, adjudication and receivables management, billing and coding services, radiology reporting, transcription services, and clinical outsourcing, among others.

Implementation of various reforms such as the American Recovery and Reinvestment Act of 2009 and the Health Information Technology for Economic and Clinical Health Act (HITECH) as well as the conversion from the ICD-9 coding system to the ICD-10 coding system (to be implemented by October 2014) has created an upward growth trend. Furthermore, constant improvements in the quality of work from destination countries have reinforced the confidence of various healthcare payers, providers, and pharmaceutical companies in outsourcing. This is considered as the key driver of the healthcare process outsourcing market. On the other hand, data security and confidentiality concerns are the restraints for the growth of the market.

The key players in this market are Accenture (Ireland), GeBBS Healthcare (U.S.), Quintiles (U.S.), Covance (U.S.), PPD (U.S.), Parexel International (U.S.), Lonza (Switzerland), Catalent (U.S.), Boehringer Ingelheim (Germany), and DSM Pharma (U.S.).

In this report, the U.S. healthcare BPO market is categorized into three segments, namely, payer outsourcing, provider outsourcing, and pharmaceutical outsourcing. Each segment is further sub-segmented on the basis of services provided. Payer services consist of claims processing, HR services, member services/customer care, and finance and accounts. Provider services include medical billing, medical coding, medical transcription, and finance and accounts. Pharmaceutical services comprise clinical research organizations (CROs), contract manufacturing organizations (CMOs), and non-clinical services. An exhaustive value analysis for all these markets is provided for 2011, 2012, and 2013, with forecast till 2018.

Scope of the Report

This research report categorizes the U.S. healthcare BPO market into the following segments and sub-segments. Each market segment is further categorized on the basis of the services provided.

The U.S. Healthcare BPO Market, by Segment:

  • Payer
  • Provider
  • Pharmaceutical

The U.S Healthcare Payer Outsourcing Market, by Services:

  • Claims Processing
  • HR Services
  • Member Services/Customer Care
  • Finance and Accounts

The U.S Healthcare Provider Outsourcing Market, by Services:

  • Medical Billing
  • Medical Coding
  • Medical Transcription
  • Finance and Accounts

The U.S Healthcare Pharmaceutical Outsourcing Market, by Services:

  • CRO Market
    • Drug Discovery
    • Pre-clinical
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
    • Clinical Data Management and Biostatistics
    • Medical Writing
    • Regulatory Services Outsourcing
    • Other Services

CMO Market

  • API Manufacturing
  • Formulation & Packaging

Non-clinical Services Market

  • Supply Chain Management and Logistics
  • Sales and Marketing Management
  • Other Non-clinical Functions

Summary

image1

Table of Contents

1 Introduction

  • 1.1 Key Take-Aways
  • 1.2 Report Description
  • 1.3 Markets Covered
  • 1.4 Stakeholders
  • 1.5 Research Methodology
    • 1.5.1 Market Size
    • 1.5.2 Key Data Points From Secondary Sources
    • 1.5.3 Key Data Points From Primary Sources
    • 1.5.4 Assumptions

2 Executive Summary

3 Market Overview

  • 3.1 Introduction
  • 3.2 Market Dynamics
    • 3.2.1 Drivers
      • 3.2.1.1 Introduction Of The Patient Protection And Affordable Care Act (PPACA)
      • 3.2.1.2 Need To Reduce Rising Healthcare Costs
      • 3.2.1.3 Shortage Of Skilled Personnel
    • 3.2.2 Restraints
      • 3.2.2.1 Unforeseen Costs
      • 3.2.2.2 Confidentiality And Security Of Data Is A Major Concern
      • 3.2.2.3 Loss Of Managerial Control
    • 3.2.3 Opportunities
      • 3.2.3.1 Consolidation Of The Healthcare System
      • 3.2.3.2 ICD-10 Conversion

4 U.S. Healthcare Payer Outsourcing Market, By Services

  • 4.1 Introduction
    • 4.1.1 Vendors With Complete Range Of Services Attract Insurance Providers
    • 4.1.2 PPACA Will Add Approximately 30 Million Americans To The Insurance System
    • 4.1.3 Errors During Client Interaction Could Affect A Company's Reputation
  • 4.2 Claims Processing
  • 4.3 Member Services/Customer Care
  • 4.4 HR Services
  • 4.5 Finance And Accounts

5 U.S. Healthcare Provider Outsourcing Market, By Services

  • 5.1 Introduction
    • 5.1.1 Outsourcing Saves Time And Costs
    • 5.1.2 Concerns Regarding Quality Of Services
  • 5.2 Medical Billing
  • 5.3 Medical Coding
  • 5.4 Medical Transcription
  • 5.5 Finance And Accounts

6 U.S. Pharmaceutical Outsourcing Market, By Type

  • 6.1 Introduction
    • 6.1.1 Outsourcing: A Cost-Effective Approach To Concentrate On Core Competencies
    • 6.1.2 Off-Patenting Of Drugs Will Drive The Outsourcing Market
    • 6.1.3 Emergence Of Biologics As A Major Opportunity In The Future
    • 6.1.4 Quality Control Issues Limit Outsourcing
  • 6.2 U.S. CRO Market
    • 6.2.1 Introduction
    • 6.2.2 Drug Discovery
    • 6.2.3 Pre-Clinical Services
    • 6.2.4 Clinical Development Phase I
    • 6.2.5 Clinical Development Phase Ii
    • 6.2.6 Clinical Development Phase Iii
    • 6.2.7 Clinical Development Phase Iv
    • 6.2.8 Clinical Data Management And Biostatistics
    • 6.2.9 Medical Writing
    • 6.2.10 Regulatory Services
    • 6.2.11 Other Services
  • 6.3 U.S. CMO Market
    • 6.3.1 Introduction
    • 6.3.2 API Manufacturing
    • 6.3.3 Formulation And Packaging
  • 6.4 U.S. Non-Clinical Services Outsourcing Market
    • 6.4.1 Introduction
    • 6.4.2 Supply Chain Management And Logistics
    • 6.4.3 Sales And Marketing Management
    • 6.4.4 Other Non-Clinical Functions

7 Geographic Analysis

  • 7.1 U.S.
    • 7.1.1 Payer
    • 7.1.2 Provider
    • 7.1.3 Pharmaceutical

8 Competitive Landscape

  • 8.1 Introduction
  • 8.2 Mergers & Acquisitions
  • 8.3 Agreements, Partnerships, Collaborations, And Joint Ventures
  • 8.4 New Product Launches
  • 8.5 Expansion

9 Company Profiles (Overview, Financials, Services, Strategy & Development)*

  • 9.1 Accenture Plc
  • 9.2 Accretive Health, Inc.
  • 9.3 Anthelio Healthcare Solutions, Inc.
  • 9.4 Boehringer Ingelheim Gmbh
  • 9.5 Catalent Pharma Solutions, Inc.
  • 9.6 Cognizant Technology Solutions Corporation
  • 9.7 Covance, Inc.
  • 9.8 GEBBS Healthcare Solutions, Inc.
  • 9.9 Genpact Limited
  • 9.10 IBM Corporation
  • 9.11 ICON Plc
  • 9.12 Infosys Bpo Limited
  • 9.13 LONZA Group Ltd.
  • 9.14 Parexel International Corporation
  • 9.15 Quintiles Transnational Holdings, Inc.
  • 9.16 WNS (Holdings) Limited

*Details On Overview, Financials, Services, Strategy& Development Might Not Be Captured In Case Of Unlisted Companies.

List Of Tables

  • Table 1 U.S. Healthcare Payer Outsourcing Market, By Services, 2011 - 2018 ($Billion)
  • Table 2 U.S. Healthcare Provider Outsourcing Market, By Services, 2011 - 2018 ($Billion)
  • Table 3 U.S. Pharmaceutical Outsourcing Market, By Type, 2011 - 2018 ($Billion)
  • Table 4 U.S. Cro Market, By Services, 2011 - 2018 ($Billion)
  • Table 5 U.S. Cmo Market, By Services, 2011 - 2018 ($Billion)
  • Table 6 U.S.Non-Clinical Services Outsourcing Market, By Services, 2011 - 2018 ($Billion)
  • Table 7 U.S.Healthcare Bpo Market, By Segments, 2011 - 2018 ($Billion)
  • Table 8 Mergers & Acquisitions, January 2011 - June 2013
  • Table 9 Agreements, Partnerships, Collaborations, Contracts & Joint Ventures, January 2011 - June 2013
  • Table 10 New Product Launches, January 2011- June 2013
  • Table 11 Expansion, January 2011 - June 2013
  • Table 12 Accenture Plc: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 13 Accretive Health, Inc.: Total Revenue, By Segment, 2009 - 2011 ($Million)
  • Table 14 Boehringer Ingelheim Gmbh: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 15 Catalent Pharma Solutions, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 16 Cognizant Technology Solutions Corporation: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 17 Covance, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 18 Genpact Limited: Total Revenue, By Service Type, 2010 - 2012 ($Million)
  • Table 19 Genpact Limited: Total Revenue, By Industry, 2010 - 2012 ($Million)
  • Table 20 IBM Corporation: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 21 ICON Plc: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 22 Infosys Limited: Total Revenue, By Segment, 2011 - 2013 ($Million)
  • Table 23 LONZA Group Ltd.: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 24 Parexel International Corporation: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 25 Quintiles Transnational Holdings, Inc.: Total Revenue, By Segment, 2010 - 2012 ($Million)
  • Table 26 WNS Holdings Ltd: Total Revenue, By Segment, 2011 - 2013 ($Million)

List Of Figures

  • Figure 1 U.S. Healthcare Bpo Market Segmentation
  • Figure 2 U.S. Healthcare Bpo Market ($Billion), 2013, By Industry
  • Figure 3 Market Dynamics
  • Figure 4 Components Of Ppaca
  • Figure 5 U.S. Healthcare Payer Outsourcing Market, By Services
  • Figure 6 U.S. Claims Processing Market, 2011 - 2018 ($Billion)
  • Figure 7 U.S. Member Services/Customer Care Market, 2011 - 2018 ($Billion)
  • Figure 8 U.S. Hr Services Market, 2011 - 2018 ($Billion)
  • Figure 9 U.S. Finance And Accounts Market, 2011 - 2018 ($Billion)
  • Figure 10 U.S. Healthcare Provider Outsourcing Market, By Services
  • Figure 11 U.S. Medical Billing Market, 2011 - 2018 ($Billion)
  • Figure 12 U.S. Medical Coding Market, 2011 - 2018 ($Billion)
  • Figure 13 U.S. Medical Transcription Market, 2011 - 2018 ($Billion)
  • Figure 14 U.S. Finance And Accounts Market, 2011 - 2018 ($Billion)
  • Figure 15 U.S. Pharmaceutical Outsourcing Market, By Services
  • Figure 16 U.S. Drug Discovery Market, 2011 - 2018 ($Billion)
  • Figure 17 U.S. Pre-Clinical Services Market, 2011 - 2018 ($Billion)
  • Figure 18 U.S. Clinical Development Phase I Market, 2011 - 2018 ($Billion)
  • Figure 19 U.S. Clinical Development Phase Ii Market, 2011 - 2018 ($Billion)
  • Figure 20 U.S. Clinical Development Phase Iii Market, 2011 - 2018 ($Billion)
  • Figure 21 U.S. Clinical Development Phase Iv Market, 2011 - 2018 ($Billion)
  • Figure 22 U.S. Clinical Data Management And Biostatistics Market, 2011 - 2018 ($Billion)
  • Figure 23 U.S. Medical Writing Market, 2011 - 2018 ($Billion)
  • Figure 24 U.S. Regulatory Services Market, 2011 - 2018 ($Billion)
  • Figure 25 U.S. Other Services Market, 2011 - 2018 ($Billion)
  • Figure 26 U.S. API Manufacturing Market, 2011 - 2018 ($Billion)
  • Figure 27 U.S. Formulation And Packaging Market, 2011 - 2018 ($Billion)
  • Figure 28 U.S. Supply Chain Management And Logistics Market, 2011 - 2018 ($Billion)
  • Figure 29 U.S. Sales And Marketing Management Market, 2011 - 2018 ($Billion)
  • Figure 30 U.S. Other Non-Clinical Functions Market, 2011 - 2018 ($Billion)
  • Figure 31 U.S. Healthcare Payer Market, By Services, 2013 - 2018 ($Billion)
  • Figure 32 U.S. Healthcare Provider Market, By Services, 2013 - 2018 ($Billion)
  • Figure 33 U.S. Pharmaceutical Outsourcing Market, By Types
  • Figure 34 Key Growth Strategies Of The U.S. Healthcare Bpo Market, 2011 - 2013
  • Figure 35 Key Players Focusing On Agreements, Partnerships, Collaborations, Contracts, And Joint Ventures Strategy, 2011 - 2013
  • Figure 36 Key Players Focusing On The Expansion Strategy, 2011 - 2013
Back to Top